JP4842400B2 - Ｇタンパク質共役型受容体変異体及びその選択方法 - Google Patents

Ｇタンパク質共役型受容体変異体及びその選択方法 Download PDF

Info

Publication number
JP4842400B2
JP4842400B2 JP2010500347A JP2010500347A JP4842400B2 JP 4842400 B2 JP4842400 B2 JP 4842400B2 JP 2010500347 A JP2010500347 A JP 2010500347A JP 2010500347 A JP2010500347 A JP 2010500347A JP 4842400 B2 JP4842400 B2 JP 4842400B2
Authority
JP
Japan
Prior art keywords
gpcr
receptor
ligand
amino acid
parent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2010500347A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010521983A (ja
JP2010521983A5 (enExample
Inventor
リチャード・ヘンダーソン
クリストファー・ゴードン・テート
フランシスカ・マグナニ
マリア・ジョセファ・セラノ−ベガ
庸子 柴田
アンソニー・ヨハネス・ウォーン
マルコム・ピーター・ウェアー
Original Assignee
ヘプテアズ・セラピューティクス・リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0705450A external-priority patent/GB0705450D0/en
Priority claimed from GB0724052A external-priority patent/GB0724052D0/en
Application filed by ヘプテアズ・セラピューティクス・リミテッド filed Critical ヘプテアズ・セラピューティクス・リミテッド
Publication of JP2010521983A publication Critical patent/JP2010521983A/ja
Publication of JP2010521983A5 publication Critical patent/JP2010521983A5/ja
Application granted granted Critical
Publication of JP4842400B2 publication Critical patent/JP4842400B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
JP2010500347A 2007-03-22 2008-03-20 Ｇタンパク質共役型受容体変異体及びその選択方法 Active JP4842400B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0705450A GB0705450D0 (en) 2007-03-22 2007-03-22 Mutant proteins and method for selecting them
GB0705450.5 2007-03-22
GB0724052.6 2007-12-08
GB0724052A GB0724052D0 (en) 2007-12-08 2007-12-08 Mutant proteins and methods for selecting them
PCT/GB2008/000986 WO2008114020A2 (en) 2007-03-22 2008-03-20 Mutant g-protein coupled receptors and methods for selecting them

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011171887A Division JP2011224018A (ja) 2007-03-22 2011-08-05 Ｇタンパク質共役型受容体変異体及びその選択方法

Publications (3)

Publication Number Publication Date
JP2010521983A JP2010521983A (ja) 2010-07-01
JP2010521983A5 JP2010521983A5 (enExample) 2010-09-24
JP4842400B2 true JP4842400B2 (ja) 2011-12-21

Family

ID=39386585

Family Applications (6)

Application Number Title Priority Date Filing Date
JP2010500347A Active JP4842400B2 (ja) 2007-03-22 2008-03-20 Ｇタンパク質共役型受容体変異体及びその選択方法
JP2011171887A Pending JP2011224018A (ja) 2007-03-22 2011-08-05 Ｇタンパク質共役型受容体変異体及びその選択方法
JP2014100213A Pending JP2014155502A (ja) 2007-03-22 2014-05-14 Ｇタンパク質共役型受容体変異体及びその選択方法
JP2016129938A Active JP6426661B2 (ja) 2007-03-22 2016-06-30 Ｇタンパク質共役型受容体変異体及びその選択方法
JP2018135756A Pending JP2018164456A (ja) 2007-03-22 2018-07-19 Ｇタンパク質共役型受容体変異体及びその選択方法
JP2020193343A Active JP7419217B2 (ja) 2007-03-22 2020-11-20 Ｇタンパク質共役型受容体変異体及びその選択方法

Family Applications After (5)

Application Number Title Priority Date Filing Date
JP2011171887A Pending JP2011224018A (ja) 2007-03-22 2011-08-05 Ｇタンパク質共役型受容体変異体及びその選択方法
JP2014100213A Pending JP2014155502A (ja) 2007-03-22 2014-05-14 Ｇタンパク質共役型受容体変異体及びその選択方法
JP2016129938A Active JP6426661B2 (ja) 2007-03-22 2016-06-30 Ｇタンパク質共役型受容体変異体及びその選択方法
JP2018135756A Pending JP2018164456A (ja) 2007-03-22 2018-07-19 Ｇタンパク質共役型受容体変異体及びその選択方法
JP2020193343A Active JP7419217B2 (ja) 2007-03-22 2020-11-20 Ｇタンパク質共役型受容体変異体及びその選択方法

Country Status (14)

Country Link
US (7) US8785135B2 (enExample)
EP (4) EP2121919B1 (enExample)
JP (6) JP4842400B2 (enExample)
CN (2) CN101688203B (enExample)
AT (1) ATE544854T1 (enExample)
AU (1) AU2008228085B2 (enExample)
CA (1) CA2681415C (enExample)
DK (1) DK2121919T3 (enExample)
ES (2) ES3008359T3 (enExample)
GB (4) GB2456235B8 (enExample)
HR (1) HRP20120336T1 (enExample)
PL (1) PL2121919T3 (enExample)
PT (1) PT2121919E (enExample)
WO (1) WO2008114020A2 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014155502A (ja) * 2007-03-22 2014-08-28 Heptares Therapeutics Ltd Ｇタンパク質共役型受容体変異体及びその選択方法

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0724051D0 (en) * 2007-12-08 2008-01-16 Medical Res Council Mutant proteins and methods for producing them
GB0724860D0 (en) * 2007-12-20 2008-01-30 Heptares Therapeutics Ltd Screening
GB0802474D0 (en) 2008-02-11 2008-03-19 Heptares Therapeutics Ltd Mutant proteins and methods for selecting them
US20110112037A1 (en) * 2008-03-05 2011-05-12 Heptares Therapeutics Limited BioPark Crystal structure
GB0910725D0 (en) 2009-06-22 2009-08-05 Heptares Therapeutics Ltd Mutant proteins and methods for producing them
GB201014715D0 (en) 2010-09-06 2010-10-20 Vib Vzw Nanobodies stabilizing functional conformational states of GPCRS
EP3333185A1 (en) 2010-08-20 2018-06-13 Heptares Therapeutics Limited Mutant gpcrs
US20140031525A1 (en) * 2011-01-21 2014-01-30 Heptares Therapeutics Limited Mutant g-protein coupled receptor proteins and methods for producing them
CA2827187C (en) 2011-02-23 2019-01-08 Massachusetts Institute Of Technology Water soluble membrane proteins and methods for the preparation and use thereof
WO2012120315A2 (en) 2011-03-10 2012-09-13 Heptares Therapeutics Limited Mutant proteins and methods for producing them
CN107739408A (zh) * 2011-08-10 2018-02-27 赫普泰雅治疗有限公司 稳定的蛋白质
ES2676827T3 (es) * 2012-06-01 2018-07-25 Heptares Therapeutics Limited Ensayos
CN105102478A (zh) 2013-01-30 2015-11-25 弗拉芒区生物技术研究所 用于筛选和药物发现目的的新型嵌合多肽
WO2014140586A2 (en) 2013-03-15 2014-09-18 Medical Research Council Mutant proteins and methods for their production
WO2014176524A2 (en) 2013-04-25 2014-10-30 The Trustees Of The University Of Pennsylvania Opioid detection based on high quality graphene transistor arrays and a synthetic mu receptor
WO2014176544A1 (en) * 2013-04-25 2014-10-30 The Trustees Of The University Of Pennsylvania Water soluble g-protein coupled receptor
CN105593240B (zh) * 2013-06-11 2024-05-31 保罗·谢勒学院 用于以单氨基酸分辨率确定可突变配体-gpcr结合的方法以及突变配体和gpcr对
US10373702B2 (en) 2014-03-27 2019-08-06 Massachusetts Institute Of Technology Water-soluble trans-membrane proteins and methods for the preparation and use thereof
CN104151401A (zh) * 2014-06-05 2014-11-19 维亚生物科技(上海)有限公司 融合表达离子通道蛋白及运输蛋白的方法及其使用的蛋白片断
GB2527286A (en) 2014-06-11 2015-12-23 Rsr Ltd Glycoprotein hormone receptor mutations
WO2016070022A1 (en) 2014-10-31 2016-05-06 Abilita Bio, Inc. Modified membrane spanning proteins and methods for the preparation and use thereof
WO2017022696A1 (ja) 2015-07-31 2017-02-09 国立研究開発法人理化学研究所 膜タンパク質の製造方法およびその利用
GB201601690D0 (en) 2016-01-29 2016-03-16 Heptares Therapeutics Ltd G proteins
EP3205450A1 (de) * 2016-02-09 2017-08-16 Hermes Schleifkörper GmbH Verfahren zur herstellung eines keramischen formkörpers
US10845367B2 (en) 2016-05-04 2020-11-24 Abilita Bio, Inc. Modified multispanning membrane polypeptides and methods of use thereof to screen therapeutic agents
CN109553687B (zh) * 2017-09-27 2021-07-06 北京大学 基于g蛋白偶联受体构建的荧光探针
US12123814B1 (en) * 2019-06-14 2024-10-22 Pierce Biotechnology, Inc. G- protein coupled receptor extraction formulations
AU2021409906A1 (en) 2020-12-23 2023-06-15 Regeneron Pharmaceuticals, Inc. Methods for obtaining antibodies that bind transmembrane proteins and cells that produce the same
CN114038498B (zh) * 2022-01-06 2022-03-18 北京晶泰科技有限公司 Gpcr的热稳定性突变预测方法、结构筛选方法及其装置

Family Cites Families (81)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) * 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
JPS61134325A (ja) 1984-12-04 1986-06-21 Teijin Ltd ハイブリツド抗体遺伝子の発現方法
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
US4946778A (en) * 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5223409A (en) * 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
ATE189526T1 (de) 1988-10-28 2000-02-15 Genentech Inc Verfahren zum nachweis von aktiven domänen und aminosäureresten in polypeptiden und hormonvarianten
US6780613B1 (en) * 1988-10-28 2004-08-24 Genentech, Inc. Growth hormone variants
US5427908A (en) 1990-05-01 1995-06-27 Affymax Technologies N.V. Recombinant library screening methods
AU665190B2 (en) 1990-07-10 1995-12-21 Cambridge Antibody Technology Limited Methods for producing members of specific binding pairs
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
WO1992009690A2 (en) 1990-12-03 1992-06-11 Genentech, Inc. Enrichment method for variant proteins with altered binding properties
ATE439435T1 (de) 1991-03-01 2009-08-15 Dyax Corp Chimäres protein mit mikroprotein mit zwei oder mehr disulfidbindungen und ausgestaltungen davon
JP3147916B2 (ja) * 1991-03-08 2001-03-19 森永製菓株式会社 体外免疫方法
DE69233750D1 (de) 1991-04-10 2009-01-02 Scripps Research Inst Bibliotheken heterodimerer Rezeptoren mittels Phagemiden
DE4122599C2 (de) 1991-07-08 1993-11-11 Deutsches Krebsforsch Phagemid zum Screenen von Antikörpern
US20030036092A1 (en) * 1991-11-15 2003-02-20 Board Of Regents, The University Of Texas System Directed evolution of enzymes and antibodies
JPH08500967A (ja) * 1992-06-12 1996-02-06 ガーヴァン インスティチュート オブ メディカル リサーチ ヒトＡ１，Ａ２ａおよびＡ２ｂアデノシン受容体をエンコードするＤＮＡ配列
US5585277A (en) * 1993-06-21 1996-12-17 Scriptgen Pharmaceuticals, Inc. Screening method for identifying ligands for target proteins
JPH10500951A (ja) 1994-05-23 1998-01-27 スミスクライン・ビーチャム・コーポレイション コードされた組合せライブラリー
US20020028443A1 (en) * 1999-09-27 2002-03-07 Jay M. Short Method of dna shuffling with polynucleotides produced by blocking or interrupting a synthesis or amplification process
AU2020497A (en) 1996-03-27 1997-10-17 Susan R. George Receptor and transporter antagonists
AU2728297A (en) * 1996-04-15 1997-11-07 Board Of Trustees Of The Leland Stanford Junior University Soluble 7-transmembrane domain G-protein-coupled receptor compositions and me thods
US6153410A (en) * 1997-03-25 2000-11-28 California Institute Of Technology Recombination of polynucleotide sequences using random or defined primers
US6555339B1 (en) 1997-04-14 2003-04-29 Arena Pharmaceuticals, Inc. Non-endogenous, constitutively activated human protein-coupled receptors
CA2323638A1 (en) * 1998-04-03 1999-10-14 Phylos, Inc. Addressable protein arrays
JP2002510790A (ja) 1998-04-06 2002-04-09 ブンセン ラッシュ ラボラトリーズ インコーポレーテッド 指向的進化バイオセンサ
US6692696B1 (en) 1998-06-18 2004-02-17 ARETé ASSOCIATES Biosensor
US7094593B1 (en) * 1998-09-01 2006-08-22 Basf Aktiengesellschaft Method for improving the function of heterologous G protein-coupled receptors
WO2000012704A2 (en) * 1998-09-01 2000-03-09 Basf Aktiengesellschaft Enhanced functional expression of g protein-coupled receptors
AU4847600A (en) 1999-05-14 2000-12-05 Repliscent, Inc. G-protein coupled receptor (gpcr) based biosensors and sense replication systems
IL149569A0 (en) * 1999-11-17 2002-11-10 Arena Pharm Inc Endogenous and non-endogenous versions of human g protein-coupled receptors
AU2001243145A1 (en) 2000-02-09 2001-08-20 Human Genome Sciences, Inc. Human g-protein chemokine receptor (ccr5) hdgnr10
US7678539B2 (en) 2000-08-10 2010-03-16 Corning Incorporated Arrays of biological membranes and methods and use thereof
AU2001286945A1 (en) * 2000-08-30 2002-03-13 John Hopkins University School Of Medicine Identification of activated receptors and ion channels
US6448377B1 (en) * 2000-09-27 2002-09-10 The Board Of Trustees Of The Leland Stanford Junior University Modified G protein sunbunits
CA2425149A1 (en) * 2000-10-26 2002-08-01 New England Medical Center Hospitals, Inc. Constitutively active, hypersensitive, and nonfunctional receptors as novel therapeutic agents
US20030232331A1 (en) * 2000-12-05 2003-12-18 Casman Stacie J. Novel proteins and nucleic acids encoding same
AU2002303091B2 (en) 2001-02-14 2006-11-09 Amgen, Inc. G-protein coupled receptor molecules and uses thereof
CN1516706A (zh) 2001-02-26 2004-07-28 阿伦纳药品公司 人g蛋白偶联受体的内源性和非内源性形式
US7208279B2 (en) * 2001-03-14 2007-04-24 Caden Biosciences, Inc. Method for identifying inhibitors of G protein coupled receptor signaling
US7294472B2 (en) 2001-03-14 2007-11-13 Caden Biosciences Method for identifying modulators of G protein coupled receptor signaling
JPWO2002079784A1 (ja) 2001-03-30 2004-07-22 サントリー株式会社 Ｇ蛋白質結合型レセプターの構造モデルおよび当該構造モデルを用いたｇ蛋白質結合型レセプターに結合するリガンドの設計方法
US20030129649A1 (en) * 2001-04-24 2003-07-10 Kobilka Brian K. Conformational assays to detect binding to G protein-coupled receptors
US20050009204A1 (en) 2003-07-11 2005-01-13 Ye Fang Multiplexed binding assays for receptor arrays
EP1438337B1 (en) 2001-10-25 2006-09-20 Astex Therapeutics Limited Crystals of cytochrome p450 2c9, structures thereof and their use
US7115377B2 (en) * 2001-10-26 2006-10-03 Atto Bioscience, Inc. Cell-based assays for G-protein-coupled receptor-mediated activities
JP2004238384A (ja) * 2002-03-28 2004-08-26 Takeda Chem Ind Ltd 新規スクリーニング方法
EP1491207A4 (en) 2002-03-28 2006-02-08 Takeda Pharmaceutical NEW SCREENING PROCESS
EP1505074A4 (en) 2002-04-24 2005-12-21 Banyu Pharma Co Ltd CONSTITUTATIVE ACTIVE MUTANTS OF A HISTAMINE H3 RECEPTOR AND ITS USES
ATE457728T1 (de) * 2002-05-01 2010-03-15 Vertex Pharma Kristallstruktur des aurora-2 proteins und dessen bindungstaschen
JP2006513702A (ja) * 2002-09-09 2006-04-27 ヌラ インコーポレーティッド Ｇタンパク質共役受容体およびその使用
AU2002951995A0 (en) * 2002-10-11 2002-10-31 Alchemia Limited Classes of compounds that interact with gpcrs
US20040096914A1 (en) 2002-11-20 2004-05-20 Ye Fang Substrates with stable surface chemistry for biological membrane arrays and methods for fabricating thereof
EP1625159B1 (en) * 2003-05-20 2011-03-02 The University Court Of The University Of Glasgow Materials and methods relating to g-protein coupled receptor oligomers
US7745161B2 (en) * 2003-12-19 2010-06-29 Palo Alto Research Center Incorporated Amplification of enzymatic reactions for use with an enthalpy array
US20050287121A1 (en) * 2004-05-12 2005-12-29 Merchiers Pascal G Methods, compositions and compound assays for inhibiting amyloid-beta protein production
WO2005121755A1 (en) 2004-06-14 2005-12-22 Commonwealth Scientific And Industrial Research Organisation Cell free g-protein coupled receptor and ligand assay
US20060188964A1 (en) 2004-07-28 2006-08-24 Filippo Mancia Processing for producing and crystallizing G-protein coupled receptors
JP2006340717A (ja) * 2005-05-11 2006-12-21 Sekisui Chem Co Ltd Ｇタンパク質共役型受容体に対する結合性評価方法及び評価用組成物、融合タンパク質、並びに、遺伝子
FR2890174B1 (fr) 2005-08-30 2009-04-24 Cis Bio Internat Sa Procede pour la mise en evidence d'un processus biologique par mesure d'un fret
US20070154947A1 (en) * 2005-08-31 2007-07-05 The Trustees Of Princeton University Chemical biodiscriminator
WO2007097820A2 (en) * 2005-11-18 2007-08-30 The Ohio State University Research Foundation Viral gene products and methods for vaccination to prevent viral associated diseases
US7495024B2 (en) * 2006-08-07 2009-02-24 Via Pharmaceuticals, Inc. Phenylalkyl N-hydroxyureas for combating atherosclerotic plaque
CN101688203B (zh) 2007-03-22 2013-12-11 赫普泰雅治疗有限公司 突变的g蛋白偶联受体及其选择方法
WO2009051769A1 (en) 2007-10-17 2009-04-23 The Board Of Trustees Of The Leland Stanford Junior University Method and composition for crystallizing g protein-coupled receptors
US8252899B2 (en) 2007-10-22 2012-08-28 The Scripps Research Institute Methods and compositions for obtaining high-resolution crystals of membrane proteins
GB0724051D0 (en) * 2007-12-08 2008-01-16 Medical Res Council Mutant proteins and methods for producing them
GB0724860D0 (en) * 2007-12-20 2008-01-30 Heptares Therapeutics Ltd Screening
GB0802474D0 (en) * 2008-02-11 2008-03-19 Heptares Therapeutics Ltd Mutant proteins and methods for selecting them
US20110112037A1 (en) * 2008-03-05 2011-05-12 Heptares Therapeutics Limited BioPark Crystal structure
GB0910725D0 (en) * 2009-06-22 2009-08-05 Heptares Therapeutics Ltd Mutant proteins and methods for producing them
EP3333185A1 (en) 2010-08-20 2018-06-13 Heptares Therapeutics Limited Mutant gpcrs
DK2611826T3 (en) 2010-08-30 2017-01-09 Confometrx Inc A method and composition for the crystallization of a family-C-GPCR
US20140031525A1 (en) * 2011-01-21 2014-01-30 Heptares Therapeutics Limited Mutant g-protein coupled receptor proteins and methods for producing them
SG194522A1 (en) 2011-05-13 2013-12-30 Receptos Inc Novel fusion partners for the purpose of crystallizing g-protein coupled receptors
CN107739408A (zh) 2011-08-10 2018-02-27 赫普泰雅治疗有限公司 稳定的蛋白质
EP2617732A1 (en) 2012-01-19 2013-07-24 Vib Vzw Tools and methods for expression of membrane proteins
WO2013142278A1 (en) 2012-03-22 2013-09-26 New York University Plasmodium vivax vaccine compositions
ES2676827T3 (es) 2012-06-01 2018-07-25 Heptares Therapeutics Limited Ensayos
WO2014028644A1 (en) 2012-08-15 2014-02-20 Cyvax, Inc. Methods and compositions for preventing a condition
US20150261911A1 (en) 2014-03-13 2015-09-17 Heptares Therapeutics Limited Crystal structure

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014155502A (ja) * 2007-03-22 2014-08-28 Heptares Therapeutics Ltd Ｇタンパク質共役型受容体変異体及びその選択方法
JP2016187348A (ja) * 2007-03-22 2016-11-04 ヘプテアズ・セラピューティクス・リミテッド Ｇタンパク質共役型受容体変異体及びその選択方法

Also Published As

Publication number Publication date
US8785135B2 (en) 2014-07-22
CN103641908A (zh) 2014-03-19
WO2008114020A3 (en) 2009-03-19
GB0901111D0 (en) 2009-03-11
EP2386635A3 (en) 2012-02-08
GB2456236B8 (en) 2009-12-09
GB2456235B8 (en) 2009-12-09
GB0805267D0 (en) 2008-04-30
CN101688203A (zh) 2010-03-31
GB2447786A (en) 2008-09-24
ES2381780T3 (es) 2012-05-31
WO2008114020A2 (en) 2008-09-25
US20180086814A1 (en) 2018-03-29
GB2456237B8 (en) 2009-12-09
ES3008359T3 (en) 2025-03-24
PL2121919T3 (pl) 2012-07-31
JP2014155502A (ja) 2014-08-28
DK2121919T3 (da) 2012-05-21
US20160052991A1 (en) 2016-02-25
EP3926045C0 (en) 2025-01-01
US11673938B2 (en) 2023-06-13
GB2456236B (en) 2009-10-28
JP2018164456A (ja) 2018-10-25
EP2450445A1 (en) 2012-05-09
HRP20120336T1 (hr) 2012-05-31
PT2121919E (pt) 2012-05-17
GB2456237B (en) 2009-10-28
GB2447786C (en) 2011-11-09
JP2021036901A (ja) 2021-03-11
JP7419217B2 (ja) 2024-01-22
EP3926045B1 (en) 2025-01-01
JP6426661B2 (ja) 2018-11-21
AU2008228085B2 (en) 2011-12-08
JP2011224018A (ja) 2011-11-10
CA2681415C (en) 2020-11-03
JP2010521983A (ja) 2010-07-01
EP3926045A1 (en) 2021-12-22
CN101688203B (zh) 2013-12-11
EP2386635A2 (en) 2011-11-16
US20100190188A1 (en) 2010-07-29
GB2456237A (en) 2009-07-15
EP2121919A2 (en) 2009-11-25
GB0901095D0 (en) 2009-03-11
GB2456236A (en) 2009-07-15
US20210061882A1 (en) 2021-03-04
US20190241644A1 (en) 2019-08-08
AU2008228085A1 (en) 2008-09-25
GB2456235A (en) 2009-07-15
GB2447786B (en) 2009-11-11
ATE544854T1 (de) 2012-02-15
US20240052017A1 (en) 2024-02-15
CA2681415A1 (en) 2008-09-25
US20120270230A1 (en) 2012-10-25
WO2008114020A9 (en) 2010-03-11
GB2456235B (en) 2009-10-28
EP2121919B1 (en) 2012-02-08
GB0901110D0 (en) 2009-03-11
JP2016187348A (ja) 2016-11-04

Similar Documents

Publication Publication Date Title
JP7419217B2 (ja) Ｇタンパク質共役型受容体変異体及びその選択方法
JP6567291B2 (ja) 変異体タンパク質とその製造方法
AU2012200841B2 (en) Mutant proteins and methods for selecting them
GB2456904A (en) Mutant neurotensin receptors with improved stability

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100412

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20100412

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20100412

A975 Report on accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A971005

Effective date: 20100518

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100525

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20100809

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100907

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20101125

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20101202

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110307

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20110405

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110805

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20110812

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20110906

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20111005

R150 Certificate of patent or registration of utility model

Ref document number: 4842400

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20141014

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

S533 Written request for registration of change of name

Free format text: JAPANESE INTERMEDIATE CODE: R313533

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: R3D02

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250